Delivery Order SPE2DB24D9105-SPE2DB25FBYVD
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,587.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 200 Unit Vials. The contract, executed on August 8, 2025, with an ultimate completion date of August 29, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,940.55 to DMS Pharmaceutical Group Inc. for Botox 200-unit vials. This firm fixed-price delivery order, issued on August 15, 2025, with an ultimate completion date of September 8, 2025, represents a pharmaceutical supply requirement fulfilled through DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA. The award carries no set-aside designation, allowing the woman-owned small business to compete on an...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $97,027.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 unit vials. The delivery order, issued on August 15, 2025, with an ultimate completion date of September 8, 2025, carries no set-aside designation. This award represents a discrete fulfillment order issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Botox 200 unit vials. The contract, valued at $5,508.60, has an ultimate completion date of April 10, 2025. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler based in Park Ridge, Illinois, that specializes in providing a comprehensive range of pharmaceutical products and medical supplies to federal government...
- The Defense Logistics Agency awarded a delivery order valued at $9,251.40 to DMS Pharmaceutical Group Inc. for BOTOX 100 unit vials on August 13, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order was issued without a set-aside designation and will be performed at the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected as the awardee based on its established...
- The Defense Logistics Agency awarded a delivery order valued at $3,881.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 Unit Vials. This firm fixed-price delivery order, issued on August 18, 2025, with an ultimate completion date of September 9, 2025, represents a single-award transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. The contract carries no...
- The Defense Logistics Agency awarded a delivery order valued at $11,101.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 100 Unit Vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and carries no set-aside designation. This award represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $5,537.76 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of Botox 100 unit vials to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 unit vials. This firm fixed-price delivery order, valued at $2,587.40, was awarded on August 13, 2025, with an ultimate completion date of September 4, 2025. The contract carries no set-aside designation, and performance will take place at the vendor's Park Ridge facility. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $6,468.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 unit vials. This firm fixed-price delivery order, issued on August 11, 2025, with an ultimate completion date of September 2, 2025, represents a tactical supply action under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA. No set-aside...
- SPE2DB24D9105Indefinite Delivery Contract
- SPE2DB24D9105-SPE2DB25FBYVDDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $2,587.40 to DMS Pharmaceutical Group Inc. for the supply of Botox 200 unit vials. The award, issued on August 18, 2025, with an ultimate completion date of September 9, 2025, represents a standard procurement with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery at its facility in Park Ridge, IL. The company is registered in SAM.gov and holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program valued at $499,999,999 through November 2026, which serves as the underlying vehicle for issuing delivery orders such as this one. This delivery order falls within DMS Pharmaceutical Group's core business of supplying pharmaceutical products and medical consumables to federal healthcare systems, particularly Department of Defense facilities. The company has demonstrated consistent success in competing for DLA pharmaceutical supply contracts, with a portfolio covering an extensive range of products including prescription medications, biologics, over-the-counter medications, and specialty pharmaceuticals. The Botox procurement supports the medical supply needs of military health facilities and exemplifies the routine pharmaceutical deliveries executed under the company's established IDC framework with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 8/18/25 |